Ziftomenib in relapsed or refractory acute myeloid leukaemia (KOMET-001): a multicentre, open-label, multi-cohort, phase 1 trial von Wang, Eunice S, Issa, Ghayas C, Erba, Harry P, Altman, Jessica K, Montesinos, Pau, DeBotton, Stephane, Walter, Roland B, Pettit, Kristen, Savona, Michael R, Shah, Mithun Vinod, Kremyanskaya, Marina, Baer, Maria R, Foran, James M, Schiller, Gary, Adès, Lionel, Heiblig, Mael, Berthon, Celine, Peterlin, Pierre, Rodríguez-Arbolí, Eduardo, Salamero, Olga, Patnaik, Mrinal M, Papayannidis, Cristina, Grembecka, Jolanta, Cierpicki, Tomasz, Clegg, Bradley, Ray, Joshua, Linhares, Brian M, Nie, Kun, Mitra, Amitava, Ahsan, Julie Mackey, Tabachri, Marilyn, Soifer, Harris S, Corum, Daniel, Leoni, Mollie, Dale, Stephen, Fathi, Amir T

Volltext

P504: UPDATED DATA FOR ZIFTOMENIB IN PATIENTS WITH NPM1-MUTATED RELAPSED OR REFRACTORY ACUTE MYELOID LEUKEMIA von Fathi, Amir, Wang, Eunice, Issa, Ghayas, Altman, Jessica, Montesinos, Pau, de Botton, Stéphane, Walter, Roland, Pettit, Kirsten, Patnaik, Mrinal, Kremyanskaya, Marina, Baer, Maria, M Foran, James, Schiller, Gary, Ades, Lionel, Heiblig, Maël, Peterlin, Pierre, Salamero Garcia, Olga, Papayannidis, Cristina, Nie, Kun, Ahsan Mackey, Julie, Tabachri, Marilyn, Corum, Daniel, Leoni, Mollie, Dale, Stephen, Erba, Harry

Volltext

PB1885: PHASE 1 STUDY OF ZIFTOMENIB IN COMBINATION WITH VENETOCLAX, VENETOCLAX/AZACITIDINE, OR STANDARD INDUCTION (7 + 3) CHEMOTHERAPY IN PATIENTS WITH ACUTE MYELOID LEUKEMIA von Zeidan, Amer M, Fathi, Amir, Issa, Ghayas, Erba, Harry, Mackey, Julie Ahsan, Corum, Daniel, Tomkinson, Blake, Kozlek, Tom, Leoni, Mollie, Wang, Eunice

Volltext

Final Results from a Phase 2 Study of Tipifarnib in Subjects with Relapsed or Refractory Peripheral T-Cell Lymphoma von Witzig, Thomas E., Sokol, Lubomir, Kim, Won Seog, de la Cruz Vicente, Fátima, Caballero, Dolores, Advani, Ranjana, de Oña, Raquel, Marin Niebla, Ana, Terol, María José, Eva, Domingo Domenech, Bendris, Nawal, Ahsan, Julie Mackey, Leoni, Mollie, Foss, Francine M.

Volltext

POSTER: AML-516 KOMET-007 Trial in Progress: A Phase I Study of Ziftomenib in Combination With Venetoclax or Venetoclax/Azacitidine, or Standard Induction Cytarabine/Daunorubicin (... von Zeidan, Amer, Fathi, Amir, Issa, Ghayas, Erba, Harry, Ahsan, Julie Mackey, Corum, Daniel, Tomkinson, Blake, Kozlek, Tom, Leoni, Mollie, Wang, Eunice

Volltext

AML-516 KOMET-007 Trial in Progress: A Phase I Study of Ziftomenib in Combination With Venetoclax or Venetoclax/Azacitidine, or Standard Induction Cytarabine/Daunorubicin (7+3) Che... von Zeidan, Amer, Fathi, Amir, Issa, Ghayas, Erba, Harry, Ahsan, Julie Mackey, Corum, Daniel, Tomkinson, Blake, Kozlek, Tom, Leoni, Mollie, Wang, Eunice

Volltext

AML-475 Activity, Tolerability, and Resistance Profile of the Menin Inhibitor Ziftomenib in Adults With Relapsed/Refractory NPM1-Mutated AML von Erba, Harry, Wang, Eunice, Issa, Ghayas, Altman, Jessica, Montesinos, Pau, DeBotton, Stephane, Walter, Roland, Pettit, Kristin, Strickland, Stephen, Patnaik, Mrinal, Kremyanskaya, Marina, Baer, Maria, Foran, James, Schiller, Gary, Ades, Lionel, Heiblig, Mael, Berthon, Celine, Grembecka, Jolanta, Cierpicki, Tomasz, Clegg, Bradley, Peterlin, Pierre, Arboli, Eduardo Rodriguez, Salamero, Olga, Papayannidis, Cristina, Nie, Kun, Ahsan, Julie Mackey, Tabachri, Marilyn, Corum, Daniel, Leoni, Mollie, Dale, Stephen, Fathi, Amir

Volltext

POSTER: AML-475 Activity, Tolerability, and Resistance Profile of the Menin Inhibitor Ziftomenib in Adults With Relapsed/Refractory NPM1-Mutated AML von Erba, Harry, Wang, Eunice, Issa, Ghayas, Altman, Jessica, Montesinos, Pau, DeBotton, Stephane, Walter, Roland, Pettit, Kristin, Strickland, Stephen, Patnaik, Mrinal, Kremyanskaya, Marina, Baer, Maria, Foran, James, Schiller, Gary, Ades, Lionel, Heiblig, Mael, Berthon, Celine, Grembecka, Jolanta, Cierpicki, Tomasz, Clegg, Bradley, Peterlin, Pierre, Arboli, Eduardo Rodriguez, Salamero, Olga, Papayannidis, Cristina, Nie, Kun, Ahsan, Julie Mackey, Tabachri, Marilyn, Corum, Daniel, Leoni, Mollie, Dale, Stephen, Fathi, Amir

Volltext

PB1885: PHASE 1 STUDY OF ZIFTOMENIB IN COMBINATION WITH VENETOCLAX, VENETOCLAX/AZACITIDINE, OR STANDARD INDUCTION (7 + 3) CHEMOTHERAPY IN PATIENTS WITH ACUTE MYELOID LEUKEMIA von Zeidan, Amer M, Fathi, Amir, Issa, Ghayas, Erba, Harry, Mackey, Julie Ahsan, Corum, Daniel, Tomkinson, Blake, Kozlek, Tom, Leoni, Mollie, Wang, Eunice

Volltext

P504: UPDATED DATA FOR ZIFTOMENIB IN PATIENTS WITH NPM1‐MUTATED RELAPSED OR REFRACTORY ACUTE MYELOID LEUKEMIA von Fathi, Amir, Wang, Eunice, Issa, Ghayas, Altman, Jessica, Montesinos, Pau, Botton, Stéphane, Walter, Roland, Pettit, Kirsten, Patnaik, Mrinal, Kremyanskaya, Marina, Baer, Maria, M Foran, James, Schiller, Gary, Ades, Lionel, Heiblig, Maël, Peterlin, Pierre, Salamero Garcia, Olga, Papayannidis, Cristina, Nie, Kun, Ahsan Mackey, Julie, Tabachri, Marilyn, Corum, Daniel, Leoni, Mollie, Dale, Stephen, Erba, Harry

Volltext